APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-opioid Topical Pain Relief

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-opioid Topical Pain Relief Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchNon-opioid Topical Pain Relief Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-opioid Topical Pain Relief Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Non-opioid Topical Pain Relief Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-opioid Topical Pain Relief Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-opioid Topical Pain Relief Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Non-opioid Topical Pain Relief market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-opioid Topical Pain Relief is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-opioid Topical Pain Relief include Teva Pharmaceutical, Sanofi, Johnson and Johnson, Mylan, Pfizer, GlaxoSmithKline, Topical BioMedics, Tibet Cheezheng Tibetan Medicine and Sun Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-opioid Topical Pain Relief market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-opioid Topical Pain Relief and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-opioid Topical Pain Relief sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-opioid Topical Pain Relief market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-opioid Topical Pain Relief Segment by Company

Teva Pharmaceutical

Sanofi

Johnson and Johnson

Mylan

Pfizer

GlaxoSmithKline

Topical BioMedics

Tibet Cheezheng Tibetan Medicine

Sun Pharmaceutical Industries

Reckitt Benckiser Group

Lingrui Pharmaceutical

Hisamitsu

China Resources Sanjiu Medical & Pharmaceutical

AdvaCare Pharma

Abacus Health Products

Non-opioid Topical Pain Relief Segment by Type

Prescription Pain Relief

Over-The-Counter Pain Relief

Non-opioid Topical Pain Relief Segment by Application

Clinic

Hospital

Pharmacy

Others

Non-opioid Topical Pain Relief Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-opioid Topical Pain Relief market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-opioid Topical Pain Relief and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-opioid Topical Pain Relief.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-opioid Topical Pain Relief market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Non-opioid Topical Pain Relief manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Non-opioid Topical Pain Relief in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Non-opioid Topical Pain Relief in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Non-opioid Topical Pain Relief Industry Trends Table 2. Non-opioid Topical Pain Relief Industry Drivers Table 3. Non-opioid Topical Pain Relief Industry Opportunities and Challenges Table 4. Non-opioid Topical Pain Relief Industry Restraints Table 5. Global Non-opioid Topical Pain Relief Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Non-opioid Topical Pain Relief Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Non-opioid Topical Pain Relief Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Non-opioid Topical Pain Relief Sales Market Share by Manufacturers Table 9. Global Non-opioid Topical Pain Relief Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Non-opioid Topical Pain Relief Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Non-opioid Topical Pain Relief Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Non-opioid Topical Pain Relief Manufacturers, Product Type & Application Table 13. Global Non-opioid Topical Pain Relief Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-opioid Topical Pain Relief by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Prescription Pain Relief Table 17. Major Manufacturers of Over-The-Counter Pain Relief Table 18. Global Non-opioid Topical Pain Relief Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Non-opioid Topical Pain Relief Sales by Type (2021-2026) & (k units) Table 20. Global Non-opioid Topical Pain Relief Sales by Type (2027-2032) & (k units) Table 21. Global Non-opioid Topical Pain Relief Sales Market Share by Type (2021-2026) Table 22. Global Non-opioid Topical Pain Relief Sales Market Share by Type (2027-2032) Table 23. Global Non-opioid Topical Pain Relief Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Non-opioid Topical Pain Relief Revenue by Type (2021-2026) & (k units) Table 25. Global Non-opioid Topical Pain Relief Revenue by Type (2027-2032) & (k units) Table 26. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2021-2026) Table 27. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Clinic Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Pharmacy Table 31. Major Manufacturers of Others Table 32. Global Non-opioid Topical Pain Relief Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Non-opioid Topical Pain Relief Sales by Application (2021-2026) & (k units) Table 34. Global Non-opioid Topical Pain Relief Sales by Application (2027-2032) & (k units) Table 35. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2021-2026) Table 36. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2027-2032) Table 37. Global Non-opioid Topical Pain Relief Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Non-opioid Topical Pain Relief Revenue by Application (2021-2026) & (k units) Table 39. Global Non-opioid Topical Pain Relief Revenue by Application (2027-2032) & (k units) Table 40. Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2021-2026) Table 41. Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2027-2032) Table 42. Global Non-opioid Topical Pain Relief Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Non-opioid Topical Pain Relief Sales by Region (2021-2026) & (k units) Table 44. Global Non-opioid Topical Pain Relief Sales Market Share by Region (2021-2026) Table 45. Global Non-opioid Topical Pain Relief Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Non-opioid Topical Pain Relief Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Non-opioid Topical Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 49. North America Non-opioid Topical Pain Relief Sales by Country (2027-2032) & (k units) Table 50. Europe Non-opioid Topical Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 52. Europe Non-opioid Topical Pain Relief Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Non-opioid Topical Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Non-opioid Topical Pain Relief Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Non-opioid Topical Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Non-opioid Topical Pain Relief Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Non-opioid Topical Pain Relief Sales by Country (2027-2032) & (k units) Table 59. Global Non-opioid Topical Pain Relief Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Non-opioid Topical Pain Relief Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Non-opioid Topical Pain Relief Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Non-opioid Topical Pain Relief Revenue Market Share by Region (2021-2026) Table 63. Global Non-opioid Topical Pain Relief Revenue Market Share by Region (2027-2032) Table 64. Teva Pharmaceutical Company Information Table 65. Teva Pharmaceutical Business Overview Table 66. Teva Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 68. Teva Pharmaceutical Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi Non-opioid Topical Pain Relief Product Portfolio Table 73. Sanofi Recent Development Table 74. Johnson and Johnson Company Information Table 75. Johnson and Johnson Business Overview Table 76. Johnson and Johnson Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolio Table 78. Johnson and Johnson Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Mylan Non-opioid Topical Pain Relief Product Portfolio Table 83. Mylan Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Non-opioid Topical Pain Relief Product Portfolio Table 88. Pfizer Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Topical BioMedics Company Information Table 95. Topical BioMedics Business Overview Table 96. Topical BioMedics Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Topical BioMedics Non-opioid Topical Pain Relief Product Portfolio Table 98. Topical BioMedics Recent Development Table 99. Tibet Cheezheng Tibetan Medicine Company Information Table 100. Tibet Cheezheng Tibetan Medicine Business Overview Table 101. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolio Table 103. Tibet Cheezheng Tibetan Medicine Recent Development Table 104. Sun Pharmaceutical Industries Company Information Table 105. Sun Pharmaceutical Industries Business Overview Table 106. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolio Table 108. Sun Pharmaceutical Industries Recent Development Table 109. Reckitt Benckiser Group Company Information Table 110. Reckitt Benckiser Group Business Overview Table 111. Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolio Table 113. Reckitt Benckiser Group Recent Development Table 114. Lingrui Pharmaceutical Company Information Table 115. Lingrui Pharmaceutical Business Overview Table 116. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 118. Lingrui Pharmaceutical Recent Development Table 119. Hisamitsu Company Information Table 120. Hisamitsu Business Overview Table 121. Hisamitsu Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Hisamitsu Non-opioid Topical Pain Relief Product Portfolio Table 123. Hisamitsu Recent Development Table 124. China Resources Sanjiu Medical & Pharmaceutical Company Information Table 125. China Resources Sanjiu Medical & Pharmaceutical Business Overview Table 126. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio Table 128. China Resources Sanjiu Medical & Pharmaceutical Recent Development Table 129. AdvaCare Pharma Company Information Table 130. AdvaCare Pharma Business Overview Table 131. AdvaCare Pharma Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolio Table 133. AdvaCare Pharma Recent Development Table 134. Abacus Health Products Company Information Table 135. Abacus Health Products Business Overview Table 136. Abacus Health Products Non-opioid Topical Pain Relief Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Abacus Health Products Non-opioid Topical Pain Relief Product Portfolio Table 138. Abacus Health Products Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Non-opioid Topical Pain Relief Distributors List Table 142. Non-opioid Topical Pain Relief Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Non-opioid Topical Pain Relief Product Image Figure 2. Global Non-opioid Topical Pain Relief Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-opioid Topical Pain Relief Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-opioid Topical Pain Relief Sales (2021-2032) & (k units) Figure 5. Global Non-opioid Topical Pain Relief Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Non-opioid Topical Pain Relief Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Prescription Pain Relief Image Figure 9. Over-The-Counter Pain Relief Image Figure 10. Global Non-opioid Topical Pain Relief Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Non-opioid Topical Pain Relief Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Non-opioid Topical Pain Relief Sales Market Share by Type (2021-2032) Figure 13. Global Non-opioid Topical Pain Relief Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Non-opioid Topical Pain Relief Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2021-2032) Figure 16. Clinic Image Figure 17. Hospital Image Figure 18. Pharmacy Image Figure 19. Others Image Figure 20. Global Non-opioid Topical Pain Relief Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Non-opioid Topical Pain Relief Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Non-opioid Topical Pain Relief Sales Market Share by Application (2021-2032) Figure 23. Global Non-opioid Topical Pain Relief Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Non-opioid Topical Pain Relief Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2021-2032) Figure 26. North America Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2032) Figure 28. U.S. Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2032) Figure 33. Germany Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2032) Figure 40. China Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Non-opioid Topical Pain Relief Sales Market Share by Country (2021-2032) Figure 48. Brazil Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Non-opioid Topical Pain Relief Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Non-opioid Topical Pain Relief Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Non-opioid Topical Pain Relief Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Figure 59. North America Non-opioid Topical Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Figure 61. Europe Non-opioid Topical Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Non-opioid Topical Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Non-opioid Topical Pain Relief Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Non-opioid Topical Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Non-opioid Topical Pain Relief Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Non-opioid Topical Pain Relief Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Prescription Pain Relief
  • Over-The-Counter Pain Relief
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Johnson and Johnson
  • Mylan
  • Pfizer
  • GlaxoSmithKline
  • Topical BioMedics
  • Tibet Cheezheng Tibetan Medicine
  • Sun Pharmaceutical Industries
  • Reckitt Benckiser Group
  • Lingrui Pharmaceutical
  • Hisamitsu
  • China Resources Sanjiu Medical & Pharmaceutical
  • AdvaCare Pharma
  • Abacus Health Products

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-opioid Topical Pain Relief Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-opioid Topical Pain Relief Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Non-opioid Topical Pain Relief Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Non-opioid Topical Pain Relief Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Non-opioid Topical Pain Relief Market Dynamics
  1. 2.1 Non-opioid Topical Pain Relief Industry Trends
  2. 2.2 Non-opioid Topical Pain Relief Industry Drivers
  3. 2.3 Non-opioid Topical Pain Relief Industry Opportunities and Challenges
  4. 2.4 Non-opioid Topical Pain Relief Industry Restraints
3 Non-opioid Topical Pain Relief Market by Manufacturers
  1. 3.1 Global Non-opioid Topical Pain Relief Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Non-opioid Topical Pain Relief Sales by Manufacturers (2021-2026)
  3. 3.3 Global Non-opioid Topical Pain Relief Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Non-opioid Topical Pain Relief Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Non-opioid Topical Pain Relief Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Non-opioid Topical Pain Relief Manufacturers, Product Type & Application
  7. 3.7 Global Non-opioid Topical Pain Relief Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Non-opioid Topical Pain Relief Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Non-opioid Topical Pain Relief Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Non-opioid Topical Pain Relief Tier 1, Tier 2, and Tier 3
4 Non-opioid Topical Pain Relief Market by Type
  1. 4.1 Non-opioid Topical Pain Relief Type Introduction
  2. 4.1.1 Prescription Pain Relief
  3. 4.1.2 Over-The-Counter Pain Relief
  4. 4.2 Global Non-opioid Topical Pain Relief Sales by Type
  5. 4.2.1 Global Non-opioid Topical Pain Relief Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-opioid Topical Pain Relief Sales by Type (2021-2032)
  7. 4.2.3 Global Non-opioid Topical Pain Relief Sales Market Share by Type (2021-2032)
  8. 4.3 Global Non-opioid Topical Pain Relief Revenue by Type
  9. 4.3.1 Global Non-opioid Topical Pain Relief Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Non-opioid Topical Pain Relief Revenue by Type (2021-2032)
  11. 4.3.3 Global Non-opioid Topical Pain Relief Revenue Market Share by Type (2021-2032)
5 Non-opioid Topical Pain Relief Market by Application
  1. 5.1 Non-opioid Topical Pain Relief Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Non-opioid Topical Pain Relief Sales by Application
  7. 5.2.1 Global Non-opioid Topical Pain Relief Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Non-opioid Topical Pain Relief Sales by Application (2021-2032)
  9. 5.2.3 Global Non-opioid Topical Pain Relief Sales Market Share by Application (2021-2032)
  10. 5.3 Global Non-opioid Topical Pain Relief Revenue by Application
  11. 5.3.1 Global Non-opioid Topical Pain Relief Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Non-opioid Topical Pain Relief Revenue by Application (2021-2032)
  13. 5.3.3 Global Non-opioid Topical Pain Relief Revenue Market Share by Application (2021-2032)
6 Global Non-opioid Topical Pain Relief Sales by Region
  1. 6.1 Global Non-opioid Topical Pain Relief Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-opioid Topical Pain Relief Sales by Region (2021-2032)
  3. 6.2.1 Global Non-opioid Topical Pain Relief Sales by Region (2021-2026)
  4. 6.2.2 Global Non-opioid Topical Pain Relief Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-opioid Topical Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Non-opioid Topical Pain Relief Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Non-opioid Topical Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Non-opioid Topical Pain Relief Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Non-opioid Topical Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Non-opioid Topical Pain Relief Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Non-opioid Topical Pain Relief Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Non-opioid Topical Pain Relief Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Non-opioid Topical Pain Relief Revenue by Region
  1. 7.1 Global Non-opioid Topical Pain Relief Revenue by Region
  2. 7.1.1 Global Non-opioid Topical Pain Relief Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Non-opioid Topical Pain Relief Revenue by Region (2021-2026)
  4. 7.1.3 Global Non-opioid Topical Pain Relief Revenue by Region (2027-2032)
  5. 7.1.4 Global Non-opioid Topical Pain Relief Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Non-opioid Topical Pain Relief Revenue (2021-2032)
  8. 7.2.2 North America Non-opioid Topical Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Non-opioid Topical Pain Relief Revenue (2021-2032)
  11. 7.3.2 Europe Non-opioid Topical Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Non-opioid Topical Pain Relief Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Non-opioid Topical Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Non-opioid Topical Pain Relief Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Non-opioid Topical Pain Relief Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Non-opioid Topical Pain Relief Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson and Johnson
  14. 8.3.1 Johnson and Johnson Company Information
  15. 8.3.2 Johnson and Johnson Business Overview
  16. 8.3.3 Johnson and Johnson Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson and Johnson Non-opioid Topical Pain Relief Product Portfolio
  18. 8.3.5 Johnson and Johnson Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Non-opioid Topical Pain Relief Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Non-opioid Topical Pain Relief Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Non-opioid Topical Pain Relief Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Topical BioMedics
  38. 8.7.1 Topical BioMedics Company Information
  39. 8.7.2 Topical BioMedics Business Overview
  40. 8.7.3 Topical BioMedics Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Topical BioMedics Non-opioid Topical Pain Relief Product Portfolio
  42. 8.7.5 Topical BioMedics Recent Developments
  43. 8.8 Tibet Cheezheng Tibetan Medicine
  44. 8.8.1 Tibet Cheezheng Tibetan Medicine Company Information
  45. 8.8.2 Tibet Cheezheng Tibetan Medicine Business Overview
  46. 8.8.3 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Tibet Cheezheng Tibetan Medicine Non-opioid Topical Pain Relief Product Portfolio
  48. 8.8.5 Tibet Cheezheng Tibetan Medicine Recent Developments
  49. 8.9 Sun Pharmaceutical Industries
  50. 8.9.1 Sun Pharmaceutical Industries Company Information
  51. 8.9.2 Sun Pharmaceutical Industries Business Overview
  52. 8.9.3 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharmaceutical Industries Non-opioid Topical Pain Relief Product Portfolio
  54. 8.9.5 Sun Pharmaceutical Industries Recent Developments
  55. 8.10 Reckitt Benckiser Group
  56. 8.10.1 Reckitt Benckiser Group Company Information
  57. 8.10.2 Reckitt Benckiser Group Business Overview
  58. 8.10.3 Reckitt Benckiser Group Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Reckitt Benckiser Group Non-opioid Topical Pain Relief Product Portfolio
  60. 8.10.5 Reckitt Benckiser Group Recent Developments
  61. 8.11 Lingrui Pharmaceutical
  62. 8.11.1 Lingrui Pharmaceutical Company Information
  63. 8.11.2 Lingrui Pharmaceutical Business Overview
  64. 8.11.3 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lingrui Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  66. 8.11.5 Lingrui Pharmaceutical Recent Developments
  67. 8.12 Hisamitsu
  68. 8.12.1 Hisamitsu Company Information
  69. 8.12.2 Hisamitsu Business Overview
  70. 8.12.3 Hisamitsu Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hisamitsu Non-opioid Topical Pain Relief Product Portfolio
  72. 8.12.5 Hisamitsu Recent Developments
  73. 8.13 China Resources Sanjiu Medical & Pharmaceutical
  74. 8.13.1 China Resources Sanjiu Medical & Pharmaceutical Company Information
  75. 8.13.2 China Resources Sanjiu Medical & Pharmaceutical Business Overview
  76. 8.13.3 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 China Resources Sanjiu Medical & Pharmaceutical Non-opioid Topical Pain Relief Product Portfolio
  78. 8.13.5 China Resources Sanjiu Medical & Pharmaceutical Recent Developments
  79. 8.14 AdvaCare Pharma
  80. 8.14.1 AdvaCare Pharma Company Information
  81. 8.14.2 AdvaCare Pharma Business Overview
  82. 8.14.3 AdvaCare Pharma Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AdvaCare Pharma Non-opioid Topical Pain Relief Product Portfolio
  84. 8.14.5 AdvaCare Pharma Recent Developments
  85. 8.15 Abacus Health Products
  86. 8.15.1 Abacus Health Products Company Information
  87. 8.15.2 Abacus Health Products Business Overview
  88. 8.15.3 Abacus Health Products Non-opioid Topical Pain Relief Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Abacus Health Products Non-opioid Topical Pain Relief Product Portfolio
  90. 8.15.5 Abacus Health Products Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-opioid Topical Pain Relief Value Chain Analysis
  2. 9.1.1 Non-opioid Topical Pain Relief Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-opioid Topical Pain Relief Production Mode & Process
  6. 9.2 Non-opioid Topical Pain Relief Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-opioid Topical Pain Relief Distributors
  9. 9.2.3 Non-opioid Topical Pain Relief Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst